Finance

Lists
Why is VYT down 2.44%?
Dive Deeper
VYT:BME
Vytrus Biotech SA
€16.00
-2.44%
(-0.40) 1D
Sep 30, 5:36:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for VYT...
Open
€16.30
High
€16.30
Low
€15.50
Mkt. cap
119.75M
Avg. vol.
2.30K
Volume
4.21K
P/E ratio
41.73
52-wk high
€20.60
52-wk low
€5.55
EPS
€0.38
Shares outstanding
7.64M
No. of employees
44
Open
€16.30
High
€16.30
Low
€15.50
Mkt. cap
119.75M
Avg. vol.
2.30K
Volume
4.21K
P/E ratio
41.73
52-wk high
€20.60
52-wk low
€5.55
EPS
€0.38
Shares outstanding
7.64M
No. of employees
44
News stories
From web sources and news partners
About Vytrus Biotech SA
CEO-
Employees44
Founded2009
Headquarters-
SectorPersonal care products
Websitevytrus.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Sep 2024
Dec 2024
Sep 2025
Revenue
1.53M
1.53M
2.33M
Cost of goods sold
164.77K
164.77K
213.27K
Cost of revenue
164.77K
164.77K
213.27K
Research and development expenses
-
-
-
Total research and development expenses
-
-
-
Selling, general, and admin expenses
1.28M
1.28M
1.71M
Operating expense
1.13M
1.13M
1.35M
Total operating expenses
1.29M
1.29M
1.57M
Operating income
236.08K
236.08K
766.56K
Other non operating income
7.05K
7.05K
-1.87K
EBT including unusual items
220.68K
220.68K
760.49K
EBT excluding unusual items
220.49K
220.49K
760.98K
Income tax expense
-34.46K
-34.47K
33.13K
Effective tax rate
-15.62%
-15.62%
4.36%
Other operating expenses
-384.52K
-384.52K
-622.89K
Net income
255.14K
255.14K
727.35K
Net profit margin
16.69%
16.69%
31.19%
Earnings per share
-
-
-
Interest and investment income
5.86K
5.86K
16.47K
Interest expense
-28.28K
-28.28K
-18.70K
Net interest expenses
-22.42K
-22.42K
-2.23K
Depreciation and amortization charges
228.17K
228.16K
263.45K
EBITDA
330.31K
284.10K
880.59K
Gain or loss from assets sale
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps